Navigation Links
Cethromycin Shown Effective Against Anthrax in Study

Advanced Life Sciences Achieves Key Endpoint in Primate Study

CHICAGO, May 02, 2007 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced that its novel respiratory antibiotic, Cethromycin, was shown to be effective in preventing inhalation anthrax infection. This conclusion was reached from a primate study where a 30-day course of oral Cethromycin was 100% protective against a lethal dose of inhaled anthrax as compared to the standard of care, Cipro(R) (ciprofloxacin), which demonstrated 90% protection.

"We felt confident going into the primate study because of Cethromycin's potent activity against over 30 strains of anthrax, yet the results have exceeded our expectations," said Dr. Michael T. Flavin, Chief Executive Officer for Advanced Life Sciences. "We believe that Cethromycin's unique antibacterial properties differentiate it from other antibiotics and, if approved by the FDA, may allow it to become a useful tool in the treatment of infections such as anthrax."

Cethromycin was recently granted Orphan Drug designation by the FDA for the prophylactic treatment of inhalation anthrax and is being developed in collaboration with U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and the NIH's National Institute of Allergy and Infectious Disease (NIAID). Cethromycin, which has been tested in over 4,400 human subjects, is also in pivotal Phase III trials for the treatment of community acquired pneumonia (CAP). The Company expects to report data from the CAP program in June of this year.

"With emerging bacterial resistance, both natural and engineered, there is a critical need for new antibiotics that work differently than currently available therapies to protect against anthrax," continued Dr. Flavin. "To our knowledge, there are no other antibiotics in late-stage development to address this need. Based on the human safety and animal efficacy dat
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
2. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
3. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
4. Gabapentin Shown Effective for Fibromyalgia Pain
5. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
6. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
7. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
8. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
9. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
10. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
11. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cethromycin Shown Effective Against Anthrax Study
(Date:7/24/2008)...., July 24 /- Ortho-McNeil Neurologic...als, Inc., announced today,that the U.S. Food and ...clusivity for TOPAMAX(R) (topiramate), based on st...y the FDA to investigate the use of TOPAMAX,in ped...nset seizures., In addition to granting pediatric...
(Date:7/24/2008)...Calif., July 24 /- Alexza,P...day that it has initiated,its second Phase 3 clini...04 is an inhalation product candidate being develo...ts with schizophrenia or bipolar disorder.,Alexza ...pharmacokinetic,(PK) properties resulting from inh...
(Date:7/24/2008)...y 24 /PRNewswire-USNewswire/ -- Headlines claiming...whole story. The small scale,preliminary study th...eproduction, is based on recollected intake of soy...s. "This study is confounded by many,issues, thus ...eal of,caution," warned Dr. Tammy Hedlund, a resea...
(Date:7/24/2008)...hermometer designed to take body temperature, for ...ewswire-FirstCall/ --- Kidz-Med, Inc.,(subsidiary ... ASFX),United States distributor of the Thermofoc...o announce the results of a clinical study,conduct...ty of Milan, in,Milan, Italy, which proves that th...
Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Human embryonic stem cell lines created that avoid immune rejection 8621 1Human embryonic stem cell lines created that avoid immune rejection 8621 2Make Safe Toys Your Holiday Priority 8619 1Make Safe Toys Your Holiday Priority 8619 2Make Safe Toys Your Holiday Priority 8619 3Fisheries should be regarded as a part of the maritime environment 1689 1Fisheries should be regarded as a part of the maritime environment 1689 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 1It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 3
...f.--(BUSINESS WIRE)--Jun 4, 2007 - Researchers at ...luminated the path,taken by human neural stem cell...nd mice, and found that the cells successfully,nav...h group placed miniscule particles of iron inside,...magnetic,resonance imaging. With the ability to mo...
... Affiliated Physicians Participate in ASCO,Proceed...ding cancer,researcher affiliated with the US Onco...ndomized, multicenter phase III trial,that compare...o,regimens of adjuvant therapy for patients with h...iven in an oral presentation by Dr.,David Loesch o...
Other Medicine Technology:Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 2Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 3Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5
(Date:7/25/2008)...CESS, N.Y., July 25 /PRNewswire-USNewswire/ -- Ant...f Quality Officer and Vice President,of Strategic ...th Fund, a,national foundation committed to improv...ted the foundation,s Program on Health Care Qualit....newscom.com/cgi-bin/prnh/20080725/DC28791LOGO ),...
(Date:7/25/2008)...ON, Calif., July 25 /PRNewswire-FirstCall/ -- Thor...n device-based mechanical,circulatory support ther...,today announced that it will report its operating...hs of fiscal 2008 on Thursday, July 31., The comp...ancial,results and operating activities to all int...
(Date:7/25/2008)...A July 24, 2008 Being overweight or obese is not...ut is also a public health issue that impacts othe...ealth Services Research reveals that the extra Me...ple could place a significant financial burden on ...dollars across the entire current Medicare populat...
(Date:7/25/2008)...July 25 /PRNewswire/ -- BeaconEquity.com announces... news today., Investors can view all of the daily...nEquity.com/m , Today,s Trade Alerts include: DUS...ok Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMed ..., Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis Inc....
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3
...n have Complication as its other name. Among the m...dreaded would be the foot ulcer, as damage can be ... with this dreaded foot ulcer, a boon in disguise ...gh voltage electric current to the skin. //Such an...
...s can also repair damaged ankles claim the researc...ing knee injuries, but it is also a valuable metho...sive surgical technique it is being applied in new... relieve different ankle problems, including ligam...
...ped on a daily basis. One of these latest laser te...ering from a degenerative eye condition. This dege...erneath the retina and leak fluid, causing scarrin...ve come up with a new therapy called the Photodyna...
... reducer Paracetamol, whose active ingredient is A...f the stroke. The fever-reducer acetaminophen lowe...e, according to a new study conducted in The Nethe...ing the first few days, though small enough that t...
Other Medicine News:Health News:Arthroscopy for Ankles 2
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r
ROB-NEL Catheters (100% Latex-Free)
Red Rubber Robinson Catheters (Latex)
Urethral Red Rubber Catheters (Latex)
Medicine Products: